Mergers and Acquisitions — The 5 Biggest Deals of Q2

These companies led the mergers and acquisitions charge in Q2

      View All  
Mergers and Acquisitions — The 5 Biggest Deals of Q2

Top Mergers and Acquisitions: Bayer (BAYRY) and Merck (MRK)

bayer bayry 185 Mergers and Acquisitions    The 5 Biggest Deals of Q2Pharmaceuticals and healthcare deals have dominated the M&A landscape since last year, so it’s no surprise Bayer’s (BAYRY) $14.2 billion buyout of Merck’s (MRK) consumer care business makes the list.

As we wrote at the time, with brands including Claritin, Coppertone, Dr. Scholl’s and Tinactin, the MRK consumer business is considered to be a crown jewel in the industry. That’s why Bayer bought it.

Merck, meanwhile, needs the $8 billion to $9 billion it expects to net from the sale to acquire or develop new blockbuster drugs to replenish its pipeline (and to quiet restive shareholders with buybacks and dividend hikes).


Article printed from InvestorPlace Media, http://investorplace.com/2014/06/mergers-and-acquisitions-buyouts/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.